Work

senchymal Stem Cell derived extracellular vesicles modulate fibrosis and autophagy in a model of diabetic nephropathy

Type: dissertation
Abstract: Introduction: Diabetic nephropathy (DN) is a complex disease and one of the major cause of end-stage renal disease (ESRD).DN is characterized by glomerular hypertrophy and hyperfiltration that cause microalbuminuria.In diabetic setting, persistent hyperglycaemia and the formation of advanced glycation endproducts (AGE) activate cellular stress pathways favouring the release of pro-inflammatory and pro-fibrotic cytokines.All these events lead to glomerular and tubule-interstitial inflammation, mesangial cell and myofibroblast expansion and fibrosis.In the recent years, different therapeutic strategies have been investigated to ameliorate kidney injury and fibrosis.Mesenchymal stem cells (MSC) and in particular their derived extracellular vesicles (MSC EVs) have been considered attractive therapeutic options due to their efficacy in different therapeutical application and low immuogenicity.It has been shown that MSC EVs contain several RNA species, including mRNAs, microRNAs (miRNAs) and long non-coding RNAs that transferred to target cells may induce epigenetic changes and functional effects.Proteins and lipids carried by EVs, are also relevant for multi-organ development, cell survival and differentiation as well as for tissue repair.Aim: In the present study, the regenerative potential of MSC derived EVs was investigated in a mouse model of DN.Their potential role in preventing progression of kidney fibrosis and the modulation of the signalling associated with autophagy were evaluated.Methods: Diabetes was induced in NSG mice by streptozotocin injection.MSC-derived EVs were administered weekly to diabetic mice for four weeks soon after diabetes onset or after one month after DN development.Kidney fibrosis and autophagy were evaluated in kidney and the expression of fibrosis and autophagy related genes were analysed.MSC EV cargo, as miRNA and protein content, was also analysed to identify molecules potentially involved in their protective effects.Results: MSC EV treatment significantly ameliorated functional parameters, such as albumin/creatinine ratio, plasma creatinine and blood urea nitrogen.Moreover, MSC EV-treated animals showed a significant reduction of kidney fibrosis confirmed by trichrome staining and by the expression of fibrotic genes whose level was partially restored.We also investigated the modulation of genes involved in autophagy by PCR array on kidney of DN mice treated one week after diabetes onset and sacrificed at week 4. MSC EVs seems to regulate the expression of key genes involved in the formation of the autophagosome and in the regulation of mTOR/PI3K pathway.All these data suggest that MSC EVs are effective in preventing DN progression.EV miRNA content was characterized and target prediction analyses demonstrated that MSC EV treatment was associated with the modulation of mTOR/PI3K, VEGF, TGFβ and AMPK pathways.Moreover, p53-apoptosis, cell cycle and ECM-receptor interaction pathways were found associated with predicted target genes for MSC EV specific miRNAs.Screening of MSC EV protein cargo identified the presence of molecules mainly related to signal transduction, cell communication, immune response and cell growth and maintenance.Among them, we identified some transcription factors such as CREBBP and PPARG that modulate TGFβ and the Wnt signalling.Conclusion: These results indicate that in diabetic setting, MSC EV administration ameliorate kidney injury by different mechanisms.
Institution: University of Turin
Language: English
Open Access status: green
OpenAlex ID: W7217974955
Cites: 130
Cited by:
Related to: 10